• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
  • Donate
  • Contact
  • Show SearchSearch

Alprazolam

August 1, 2024

Selected References

  • Anderson PO, McGuire GG. 1989. Neonatal alprazolam withdrawal – possible effects of breastfeeding. DICP. 23:614. Letter.
  • Andrade C. 2019. Gestational Exposure to Benzodiazepines, 1: The Risk of Spontaneous Abortion Examined Through the Prism of Research Design. J Clin Psychiatry.;80(5):19f13076
  • Barry WS, St. Clair SM. 1987. Exposure to benzodiazepines in utero. Lancet. 1:1436-7.
  • Browne JL, Hauge KJ. 1986. A review of alprazolam withdrawal. Drug Intell Clin Pharm; 20(11):837-41.
  • Eros E, et al. 2002. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 101:147-54.
  • Freeman MP, et al. 2018. Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders. Gen Hosp Psychiatry. 53:73-79.
  • Furugen A, et al. 2019. Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: Application to evaluation of alprazolam transfer into breastmilk. J Pharm Biomed Anal. 168:83-93.
  • García-Algar O, et al. 2007. Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis. Clin Toxicol (Phila). 45(3):295-8.
  • Grigoriadis S, er al. 2019. Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis. J Clin Psychiatry. 80(4):18r12412
  • Ito S, et al. 1993. Prospective follow-up of adverse reactions in breastfed infants exposed to maternal medication. Am J Obstet Gynecol. 168:1393-9.
  • Källén B, et al. 2013. The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel). 6(10):1221-86.
  • Kelty E, et al. 2023. Safety of alprazolam use in pregnancy in Western Australia: A retrospective cohort study using linked health data. J of Psychoactive Drugs. 1-7.
  • Lee H, et al. 2022. Pregnancy and Neonatal Outcomes After Exposure to Alprazolam in Pregnancy. Front Pharmacol. 25: 13:854562.
  • Mazzilli R, et al. 2021. Psychotropic Drugs Levels in Seminal Fluid: A New Therapeutic Drug Monitoring Analysis?. Front Endocrinol (Lausanne). 12:620936.
  • Meng LC, et al. 2024. Benzodiazepine Use During Pregnancy and Risk of Miscarriage. JAMA Psychiatry. 81(4):366-373.
  • Munjack DJ, Crocker B. 1986. Alprazolam-induced ejaculatory inhibition. J Clin Psychopharmacol 6:57-8.
  • Ogawa Y, et al. 2018. Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: A case-control study using a claims database in Japan. Asia Pac Psychiatry. 2018 Sep;10(3):e12309
  • Nishimura A, et al. 2021. Benzodiazepine Concentrations in the Breast Milk and Plasma of Nursing Mothers: Estimation of Relative Infant Dose. Breastfeed Med. 16(5): 424-432.
  • Noh Y, et al. 2022. First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: A population-based cohort study in South Korea. PLoS Med. 2022;19(3):e1003945
  • Nonacs R. 2020. “Benzodiazepines and Risk of Ectopic Pregnancy”. MGH Center for Women’s Mental Health. https://womensmentalhealth.org/posts/benzodiazepine-ectopic/. Psychiatric Disorder during Pregnancy
  • Nonacs R. 2019. “Benzodiazepines During Early Pregnancy and risk of Miscarriage”. MGH Center for Women’s Mental Health. https://womensmentalhealth.org/posts/benzodiazepine-during-early-pregnancy-and-risk-of-miscarriage-2/. Anxiety Disorder, June. Pregnancy Loss, Pregnancy Outcome.
  • Nonacs R. 2019. “Interpreting New Data on the Use of Benzodiazepines During Pregnancy. MGH Center for Women’s Mental Health. https://womensmentalhealth.org/posts/interpreting-new-data-on-the-use-of-benzodiazepines-during-pregnancy/. December. Psychiatric Disorders during Pregnancy
  • Oo CY, et al. 1995. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br J Clin Pharmacol. 40:231-6.
  • Petric D, et al. 2011. High doses alprazolam induced amenorrhoea and galactorrhoea. Psychiatr Danub. 23(1):123-4.
  • Sheehy O, et al. 2019. Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion. JAMA Psychiatry. 76(9): 948–957.
  • Shyken JM, et. Al. 2019. Benzodiazepines in Pregnancy. Clin Obstet Gynecol.;62(1):156-167
  • St Clair SM, Schnirmer RG. 1992. First-trimester exposure to alprazolam. Obstet Gynecol. 80:843-846.
  • Tinker SC, et al; National Birth Defects Prevention Study. 2019. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011. Birth Defects Res; 111(10):613-620.
  • Wall-Wieler et al. 2020. Benzodiazepine use before conception and risk of ectopic pregnancy. Human Reproduction, Vol.35, No.7, pp. 1685–1692.
  • Wisner KL, Yonkers KA. 2019. Are Adverse Reproductive Outcomes Associated With the Illness or Its Treatment (or Both)?. JAMA Psychiatry. 2019;76(12):1317-1318
  • Yamamoto K, et al. 2019. Pharmacokinetic assessment of alprazolam-induced neonatal abstinence syndrome using physiologically based pharmacokinetic model. Drug Metab Pharmacokinet. 34(6):400-402.

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.